Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission-Reference-Cited by-同舟云学术

Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission

Published:2012-08-11 Issue:9 Volume:188 Page:777-781
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Matuschek C.,Bölke E.,Roth S.L.,Orth K.,Lang I.,Bojar H.,Janni J.W.,Audretsch W.,Nestle-Kraemling C.,Lammering G.,Speer V.,Gripp S.,Gerber P.A.,Buhren B.A.,Sauer R.,Peiper M.,Schauer M.,Dommach M.,Struse-Soll K.,Budach W.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s00066-012-0162-8.pdf

Reference24 articles.

1. Roth SL, Audretsch W, Bojar H et al (2010) Retrospective study of neoadjuvant versus adjuvant radiochemotherapy in locally advanced noninflammatory breast cancer: survival advantage in cT2 category by neoadjuvant radiochemotherapy. Strahlenther Onkol 186:299–306

2. Hung WK, Lau Y, Chan CM, Yip AW (2000) Experience of neoadjuvant chemotherapy for breast cancer at a public hospital: retrospective study. Hong Kong Med J 6:265–268

3. Jiralerspong S, Palla SL, Giordano SH et al (2009) Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 27:3297–3302

4. Fangberget A, Nilsen LB, Hole KH et al (2011) Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol 21:1188–1199

5. Wildiers H, Neven P, Christiaens MR et al (2011) Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancer. Ann Oncol 22:588–594

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Präoperative Radiotherapie versus postoperative Radiotherapie nach neoadjuvanter Chemotherapie („NeoRad“) beim Hochrisikomammakarzinom: eine prospektive, randomisierte, internationale multizentrische Phase-III-Studie;Die Onkologie;2024-08-08

2. Neoadjuvant radiochemotherapy is safe and feasible for breast conserving surgery or immediate reconstruction;Scientific Reports;2024-04-22

3. Non-Surgical Definitive Treatment for Operable Breast Cancer: Current Status and Future Prospects;Cancers;2023-03-20

4. The Role of Radiotherapy for Patients with Unresectable Locally Advanced Breast Cancer following Neoadjuvant Systemic Therapy;Journal of Oncology;2023-02-17

5. Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery;Advances in Radiation Oncology;2023-01